XML 20 R14.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Common and Preferred Stock (Notes) | 12 Months Ended
--- | ---
Dec. 28, 2019
Stockholders' Equity Note [Abstract] |
Common and Preferred Stock | COMMON AND PREFERRED STOCK (a) Shares Authorized At December 28, 2019 and December 29, 2018, the company had 95,000,000 authorized shares of common stock and 2,000,000 authorized shares of non-voting preferred stock. (b) Treasury Stock In November 2017, the company's Board of Directors approved a stock repurchase program authorizing the company to repurchase in the aggregate up to 2,500,000 shares of its outstanding common stock. As of December 28, 2019, 126,200 shares had been purchased under the 2017 stock repurchase program and 2,373,800 remain authorized for repurchase. (c) Share-Based Awards The company maintains several stock incentive plans under which the company's Board of Directors issues restricted share grants to key employees. Restricted share grants issued to employees are transferable upon certain vesting requirements being met. The 2011 Stock Incentive Plan (the "2011 Plan") was adopted on April 1, 2011, under which the company's Board of Directors issues stock grants to key employees. On July 11, 2017 the company increased the maximum amount of shares reserved for issuance under the 2011 Plan by 1,000,000. A maximum amount of 2,650,000 shares can be issued under the 2011 Plan. Stock grants issued to employees are transferable upon certain vesting requirements. As of December 28, 2019, a total of 1,652,175 share-based awards have been issued under the 2011 Plan. This includes 1,652,175 restricted share grants, of which 527,085 remain outstanding and unvested. For fiscal year ended December 28, 2019, the approximate fair value of shares vested were $16.5 million. A summary of the company’s nonvested restricted share grant activity for fiscal years ended December 28, 2019 and December 29, 2018 is as follows:
| Shares |  |  | Weighted Average Grant-Date Fair Value |
Nonvested shares at December 30, 2017 | 159,203 |  |  | $ | 104.44 |
Granted | 132,038 |  |  | 100.50 |
Vested | (6,203 | ) |  | 126.09 |
Forfeited | (159,196 | ) |  | 100.84 |
Nonvested shares at December 29, 2018 | 125,842 |  |  | $ | 103.29 |
Granted | 537,059 |  |  | 113.26 |
Vested | (135,816 | ) |  | 105.81 |
Forfeited | — |  |  | — |
Nonvested shares at December 28, 2019 | 527,085 |  |  | $ | 112.60 |

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration